Baird analyst Vikram Kesavabhotla downgrades Signify Health (NYSE:SGFY) from Outperform to Neutral and raises the price target from $28 to $30.5.
Baird Downgrades Signify Health to Neutral, Raises Price Target to $30.5
Baird analyst Vikram Kesavabhotla downgrades Signify Health (NYSE:SGFY) from Outperform to Neutral and raises the price target from $28 to $30.5.